Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BWAY NYSE:ELMD NASDAQ:GUTS NASDAQ:SURG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBWAYBrainsway$13.10+1.8%$10.75$5.98▼$13.66$247.57M1.467,602 shs29,801 shsELMDElectromed$20.22+1.0%$21.03$13.74▼$35.56$169.48M0.4189,955 shs49,004 shsGUTSFractyl Health$1.50$1.81$0.87▼$4.92$73.72M1.58367,516 shs181,751 shsSURGSurgePays$3.30-3.8%$2.91$1.05▼$3.47$66.95M0.46626,832 shs33,188 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBWAYBrainsway-3.74%-0.85%+23.16%+46.92%+109.27%ELMDElectromed-0.50%-8.17%-4.44%-14.92%+34.91%GUTSFractyl Health-2.60%-5.06%-24.62%+50.02%-65.28%SURGSurgePays+3.94%+12.09%+22.06%+45.96%+19.51%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBWAYBrainsway1.0887 of 5 stars1.53.00.00.00.60.81.9ELMDElectromed1.5068 of 5 stars2.05.00.00.00.61.70.6GUTSFractyl Health2.0203 of 5 stars3.53.00.00.01.10.00.0SURGSurgePays3.0542 of 5 stars3.55.00.00.01.31.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBWAYBrainsway 3.00Buy$14.258.78% UpsideELMDElectromed 4.00Strong Buy$38.0087.93% UpsideGUTSFractyl Health 3.00Buy$11.00633.33% UpsideSURGSurgePays 3.00Buy$9.00172.73% UpsideCurrent Analyst Ratings BreakdownLatest SURG, GUTS, BWAY, and ELMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/16/2025SURGSurgePaysAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$8.75 ➝ $9.006/9/2025BWAYBrainswayHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$16.005/15/2025ELMDElectromedB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/22/2025SURGSurgePaysAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$8.50 ➝ $8.754/15/2025GUTSFractyl HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$12.00(Data available from 7/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBWAYBrainsway$41.02M6.04$0.24 per share53.62$3.31 per share3.96ELMDElectromed$61.44M2.76$0.49 per share41.36$5.10 per share3.96GUTSFractyl Health$90K816.33N/AN/A$0.59 per share2.54SURGSurgePays$60.88M1.11N/AN/A$0.76 per share4.34Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBWAYBrainsway$2.92M$0.2065.5081.88N/A9.01%7.35%4.72%8/5/2025 (Estimated)ELMDElectromed$5.15M$0.7926.95∞N/A11.34%15.71%13.37%N/AGUTSFractyl Health-$68.69M-$1.85N/AN/AN/A-73,864.52%-228.66%-76.74%8/13/2025 (Estimated)SURGSurgePays-$45.73M-$2.79N/AN/AN/A-136.37%-206.01%-153.67%8/12/2025 (Estimated)Latest SURG, GUTS, BWAY, and ELMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2025Q2 2025BWAYBrainsway$0.07N/AN/AN/A$12.34 millionN/A5/13/2025Q1 2025BWAYBrainsway$0.02$0.04+$0.02$0.04$11.45 million$11.54 million5/13/2025Q1 2025GUTSFractyl Health-$0.49-$0.49N/A-$0.49N/AN/A5/13/2025Q1 2025SURGSurgePays-$0.40-$0.38+$0.02-$0.38$9.80 million$10.58 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBWAYBrainswayN/AN/AN/AN/AN/AELMDElectromedN/AN/AN/AN/AN/AGUTSFractyl HealthN/AN/AN/AN/AN/ASURGSurgePaysN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBWAYBrainswayN/A5.034.75ELMDElectromedN/A5.104.74GUTSFractyl Health4.612.502.50SURGSurgePays0.241.721.41Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBWAYBrainsway30.11%ELMDElectromed40.82%GUTSFractyl HealthN/ASURGSurgePays6.94%Insider OwnershipCompanyInsider OwnershipBWAYBrainsway19.00%ELMDElectromed14.00%GUTSFractyl HealthN/ASURGSurgePays30.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBWAYBrainsway12018.90 million15.31 millionNot OptionableELMDElectromed1608.39 million7.36 millionOptionableGUTSFractyl Health10248.98 millionN/AN/ASURGSurgePays4020.41 million14.19 millionOptionableSURG, GUTS, BWAY, and ELMD HeadlinesRecent News About These CompaniesSurgePays Launches New PrePaid Service Smartphones Designed For Convenience Stores And Non-Wireless Retail ChannelsJuly 3, 2025 | twice.comTSurgePays (NASDAQ:SURG) Share Price Passes Above 200 Day Moving Average - Here's What HappenedJuly 2, 2025 | marketbeat.comGPOPlus+ Shareholder UpdateJune 30, 2025 | accessnewswire.comASurgePays launches prepaid phone-in-a-box service for convenience storesJune 27, 2025 | investing.comSurgePays Launches New Prepaid Service, "Phone-in-a-Box," Designed for Convenience Stores and Non-Wireless Retail ChannelsJune 26, 2025 | prnewswire.comSurgePays (NASDAQ:SURG) Share Price Crosses Above Two Hundred Day Moving Average - Here's WhyJune 24, 2025 | marketbeat.comSurgePays (NASDAQ:SURG) Price Target Raised to $9.00June 16, 2025 | marketbeat.comSurgePays to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference on June 24-25June 11, 2025 | prnewswire.comSurgePays Confirms Directors and Ratifies Accounting FirmMay 20, 2025 | tipranks.comAT&T (NYSE:T) Partners With Carbyne For APEX Continuity Emergency Solution For PSAPsMay 20, 2025 | finance.yahoo.comUS$8.75 - That's What Analysts Think SurgePays, Inc. (NASDAQ:SURG) Is Worth After These ResultsMay 17, 2025 | uk.finance.yahoo.comSurgePays Secures $7M Convertible Note for ExpansionMay 16, 2025 | tipranks.comWhy SurgePays, Inc.’s (SURG) Stock Is Down 19.64%May 15, 2025 | aaii.comAQ1 2025 Surgepays Inc Earnings CallMay 15, 2025 | uk.finance.yahoo.comSurgePays, Inc. (SURG) Q1 2025 Earnings Call TranscriptMay 13, 2025 | seekingalpha.comSurgePays, Inc. (SURG) Reports Q1 Loss, Tops Revenue EstimatesMay 13, 2025 | zacks.comSurgePays Reports First Quarter 2025 Financial ResultsMay 13, 2025 | prnewswire.comSurgePays Announces $7 Million Debt Financing to Accelerate GrowthMay 13, 2025 | prnewswire.comSurgePays to Host First Quarter 2025 Financial Results Conference Call on Tuesday, May 13thMay 6, 2025 | prnewswire.comEarnings Preview: SurgePays, Inc. (SURG) Q1 Earnings Expected to DeclineMay 5, 2025 | zacks.comPOS Fintech SurgePays Launches on AT&TApril 28, 2025 | crowdfundinsider.comCNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge3 Semiconductor Stocks Poised to Surge on AI SpendingBy Chris Markoch | June 25, 2025View 3 Semiconductor Stocks Poised to Surge on AI SpendingMore Than a Monetary Metal: Silver's Case for OutperformanceBy Jeffrey Neal Johnson | June 22, 2025View More Than a Monetary Metal: Silver's Case for OutperformanceRocket Lab: Latest Catalysts Bolster the Bull CaseBy Ryan Hasson | July 3, 2025View Rocket Lab: Latest Catalysts Bolster the Bull CaseMarvell's New AI Chip Deals Capture Wall Street’s AttentionBy Jeffrey Neal Johnson | June 21, 2025View Marvell's New AI Chip Deals Capture Wall Street’s AttentionSURG, GUTS, BWAY, and ELMD Company DescriptionsBrainsway NASDAQ:BWAY$13.10 +0.23 (+1.79%) As of 02:14 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.Electromed NYSE:ELMD$20.22 +0.20 (+1.00%) As of 02:14 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.Fractyl Health NASDAQ:GUTS$1.50 0.00 (0.00%) As of 02:14 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.SurgePays NASDAQ:SURG$3.30 -0.13 (-3.79%) As of 02:10 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.SurgePays, Inc., together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities. SurgePays, Inc. is headquartered in Bartlett, Tennessee. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SoundHound Rises as Short Sellers Exit and AI Demand Grows Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Palantir’s Revenue Surge to $1B: Growth vs. Valuation Chime Financial: Analysts Ring In—And It’s a Buy Is Fortinet Ready to Break Out After Months of Consolidation? AST SpaceMobile: Is Market Noise Drowning Out a $100M Signal? CoreWeave's $9 Billion Power Play for Core Scientific Taiwan Semiconductor May Profit from Chinese Manufacturing Issues Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
